How to Verify FDA Tissue Bank Registration for Distributors

To verify FDA tissue bank registration for biologic distributors, access the FDA Establishment Registration & Human Cell and Tissue Product Offerings database and search by the distributor's legal business name, location, or FDA Establishment Identifier (FEI) number. Practice managers must confirm that both the primary tissue processing facility and the secondary distributor maintain active Form FDA 3356 registrations under 21 CFR Part 1271 for the specific human cell, tissue, or cellular and tissue-based product (HCT/P) categories being procured.

Verifying active regulatory status ensures your clinical facility maintains strict chain-of-custody compliance, mitigates regulatory liability, and guarantees that all tissue products meet federal donor screening and processing standards.

Regulatory Framework: Understanding 21 CFR Part 1271 and Form FDA 3356

The regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps) falls under Title 21 of the Code of Federal Regulations, Part 1271 (21 CFR Part 1271). This framework establishes a unified system to prevent the introduction, transmission, and spread of communicable diseases through the use of biologic tissue products. Entities that recover, process, store, label, package, or distribute HCT/Ps are legally required to register with the U.S. Food and Drug Administration (FDA) using Form FDA 3356.

It is critical for practice administrators to distinguish between FDA registration and FDA approval. Under Section 361 of the Public Health Service (PHS) Act, tissue products that are minimally manipulated and intended for homologous use are regulated solely to prevent disease transmission. These products do not undergo the pre-market approval pathways required for biological drugs governed by Section 351. Consequently, an active FDA tissue establishment registration indicates that an entity has declared its operations to the agency and is subject to inspection, but it does not represent an endorsement or clinical safety approval by the FDA.

When sourcing biologics such as amniotic tissue, umbilical cord derivatives, or allograft matrix products, medical practice procurement managers must verify registration for every point in the supply chain—from the donor recovery organization and tissue processor to the third-party distributor delivering product to your clinic.

Step-by-Step Checklist: How to Verify FDA Tissue Registration

Before executing procurement agreements or placing clinical orders, practice managers should execute a standard operating procedure (SOP) to verify vendor compliance. Follow this structured verification protocol:

1. Request Form FDA 3356 from the Vendor

Ask the distributor for a current copy of their Form FDA 3356 (Establishment Registration and Listing for Human Cells, Tissues, and Cellular and Tissue-Based Products). Ensure the document displays an active registration status for the current calendar year.

1. Identify the Tissue Processor vs. Distributor

Determine whether the vendor is the primary manufacturer/processor or a secondary distributor. If the vendor acts as a distributor, request the legal name and FEI number of the primary tissue bank that processes the tissue.

1. Query the Official FDA eBIMS Database

Access the public FDA Human Cell and Tissue Establishment Registration electronic database. Input the vendor's legal business name, address, or FEI number into the search interface to verify that their listed status is marked as "Registered."

1. Validate Tissue Category Functions

Confirm that the registration explicitly covers the operational functions the vendor performs (e.g., "Distribute") and lists the specific tissue types being purchased (e.g., musculoskeletal tissue, skin allografts, amniotic membrane).

1. Cross-Reference Annual Renewal Dates

FDA tissue registration must be updated annually between October 1 and December 31. Verify that the registration has not lapsed into an inactive or delinquent status.

1. Request a Certificate of Analysis (CoA) Sample

Obtain lot-specific CoAs that document infectious disease testing results (including HIV, Hepatitis B, Hepatitis C, and Syphilis) conducted by a CLIA-certified laboratory prior to product release.

Clinical Considerations for Physicians and Treating Clinicians

For medical directors, orthopedic surgeons, and clinicians working in pain management practices, regulatory verification is directly tied to patient safety and clinical predictability. While practice managers handle administrative vendor screening, treating physicians carry ultimate responsibility for products applied in patient care.

Clinicians must ensure that the biologic tissue products selected align with established standards for minimal manipulation and homologous use. Homologous use means the tissue performs the same basic function in the recipient as in the donor—such as structural support or barrier function in soft tissue applications. Utilizing an HCT/P outside of its established homologous intended use without an Investigational New Drug (IND) application can subject a practice to regulatory scrutiny.

Furthermore, physicians should review the vendor’s processing protocols to verify that cell viability, structural integrity, and sterility standards meet clinical expectations. Establishing clear protocol alignment between clinical needs and verified vendor capabilities ensures that tissue allografts arrive with consistent quality, validated donor testing, and complete batch documentation.

Vendor Auditing: Storage, Cold-Chain Maintenance, and Logistics

Verifying database registration is an essential first step, but operational compliance requires auditing vendor storage and transportation infrastructure. Biologic tissue integrity depends entirely on uninterrupted thermal management throughout the supply chain.

When auditing a biologic distributor, practice managers should evaluate:

• Cold-Chain Documentation: Does the distributor use calibrated, continuously monitored refrigeration units (e.g., -80°C ultralow freezers or cryopreservation tanks) equipped with automated temperature logging and redundant alarm systems?
• Validated Shipping Containers: Are shipments sent using validated thermal packaging systems with validated temperature indicators to prove the product remained within specified thermal limits during transit?
• Batch Traceability SOPs: Can the distributor track a single lot or tissue identification number from the receiving clinical facility back to the donor source within a specified timeframe in the event of a product recall or adverse reaction inquiry?

Reviewing these operational capabilities ensures that your practice does not absorb liability resulting from compromised shipping conditions or incomplete chain-of-custody tracking.

Practice Management & Operational Compliance: What This Means for Your Practice

Establishing a rigorous compliance verification process protects your facility against regulatory enforcement, civil liability, and supply chain disruptions. Integrating vendor verification into your procurement workflow involves concrete, actionable steps for administrative staff:

• Archive Vendor Compliance Packets: Maintain a centralized digital repository containing current Form FDA 3356 copies, state tissue bank licenses (where applicable, such as Texas, California, or New York), and Certificates of Analysis for every tissue lot ordered. Retain these records according to state regulatory requirements, typically a minimum of 10 years.
• Standardize Receiving Inspection SOPs: Train clinical receiving staff to inspect every tissue delivery for packaging integrity, correct temperature indicators, matching lot numbers, and accompanying documentation before logging the product into practice inventory.
• Schedule Annual Vendor Reviews: Set an automated administrative calendar reminder every November to request updated FDA registration renewals from all active biologic distributors prior to the December 31 deadline.
• Audit Legal Structure and Licensing: Confirm that your distributor operates under valid state distribution licenses in addition to federal FDA registration. Review corporate history and operational experience by evaluating the vendor's background on their about page.

Establishing Vendor Verification Standards

Navigating regulatory compliance and vendor selection requires structured processes that protect practice operations and clinical integrity. By implementing systematic verification of FDA Form 3356 registration, cold-chain logistics, and donor testing records, medical practices ensure that all biologic products meet the highest safety and regulatory standards.

To consult with our medical procurement specialists regarding compliant biologic sourcing, tissue traceability, or clinical product lines for your practice, visit our contact page or explore our detailed regulatory guides in our frequently asked questions.